Orly Eizenberg

1.5k total citations
31 papers, 1.3k citations indexed

About

Orly Eizenberg is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Orly Eizenberg has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 13 papers in Immunology and 10 papers in Hematology. Recurrent topics in Orly Eizenberg's work include Chemokine receptors and signaling (14 papers), Immunotherapy and Immune Responses (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Orly Eizenberg is often cited by papers focused on Chemokine receptors and signaling (14 papers), Immunotherapy and Immune Responses (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Orly Eizenberg collaborates with scholars based in Israel, Isle of Man and United States. Orly Eizenberg's co-authors include Anat Faber‐Elman, Moshe Oren, Michal Schwartz, Eyal Gottlieb, Varda Rotter, Amnon Peled, Michal Abraham, Katia Beider, Hanna Wald and Eithan Galun and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Orly Eizenberg

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Orly Eizenberg Israel	16	488	468	338	236	181	31	1.3k
Yoko Hamazaki Japan	25	290 0.6×	752 1.6×	861 2.5×	117 0.5×	215 1.2×	49	2.2k
Melanie Laschinger Germany	20	622 1.3×	534 1.1×	1.2k 3.6×	92 0.4×	159 0.9×	37	2.4k
Barry J. Dussault United States	10	601 1.2×	514 1.1×	798 2.4×	399 1.7×	157 0.9×	11	2.2k
Anne Rensing‐Ehl Germany	21	286 0.6×	602 1.3×	865 2.6×	134 0.6×	127 0.7×	27	1.7k
Xuejun Zhu China	22	292 0.6×	392 0.8×	693 2.1×	75 0.3×	99 0.5×	54	1.6k
Jay Myers United States	19	433 0.9×	519 1.1×	577 1.7×	101 0.4×	48 0.3×	45	1.4k
Sarah Shapiro Israel	17	235 0.5×	334 0.7×	332 1.0×	176 0.7×	162 0.9×	34	1.3k
Paola Gasperini United States	19	393 0.8×	370 0.8×	186 0.6×	64 0.3×	141 0.8×	26	970
Fumi Shibata Japan	14	235 0.5×	912 1.9×	520 1.5×	263 1.1×	130 0.7×	22	1.6k

Countries citing papers authored by Orly Eizenberg

Since Specialization

Citations

This map shows the geographic impact of Orly Eizenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orly Eizenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orly Eizenberg more than expected).

Fields of papers citing papers by Orly Eizenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orly Eizenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orly Eizenberg. The network helps show where Orly Eizenberg may publish in the future.

Co-authorship network of co-authors of Orly Eizenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Orly Eizenberg. A scholar is included among the top collaborators of Orly Eizenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orly Eizenberg. Orly Eizenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abraham, Michal, et al.. (2021). The High Affinity CXCR4 Inhibitor, BL-8040, Impairs the Infiltration, Migration, Viability, and Differentiation of Regulatory T Cells. Blood. 138(Supplement 1). 2804–2804. 2 indexed citations

Abraham, Michal, Yaron Pereg, Baruch Bulvik, et al.. (2017). Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers. Clinical Cancer Research. 23(22). 6790–6801. 41 indexed citations

Klein, Shiri, Michal Abraham, Baruch Bulvik, et al.. (2017). CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways. Cancer Research. 78(6). 1471–1483. 48 indexed citations

Abraham, Michal, Shiri Klein, Baruch Bulvik, et al.. (2017). The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression. Leukemia. 31(11). 2336–2346. 86 indexed citations

Abraham, Michal, Hanna Wald, Valentin Grabovsky, et al.. (2017). Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation. Frontiers in Immunology. 8. 1432–1432. 10 indexed citations

Beider, Katia, Merav Darash‐Yahana, Maya Koren‐Michowitz, et al.. (2014). Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo. Molecular Cancer Therapeutics. 13(5). 1155–1169. 51 indexed citations

Peled, Amnon, Michal Abraham, Irit Avivi, et al.. (2013). The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma. Clinical Cancer Research. 20(2). 469–479. 70 indexed citations

Beider, Katia, Elena Ribakovsky, Michal Abraham, et al.. (2013). Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140. Clinical Cancer Research. 19(13). 3495–3507. 48 indexed citations

Weiss, Ido D., Michal Abraham, Katia Beider, et al.. (2012). In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 144(5). 1167–1175.e1. 56 indexed citations

10.

Beider, Katia, Elena Ribakovsky, Michal Abraham, et al.. (2011). CXCR4 Antagonist BKT140 Synergizes with Rituximab, Targeting Non Hodgkin Lymphoma (NHL) In Vitro and In Vivo in a Xenograft Model with Bone Marrow Involvement. Blood. 118(21). 952–952. 2 indexed citations

11.

Beider, Katia, Michal Abraham, Hanna Wald, et al.. (2010). CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth. Experimental Hematology. 39(3). 282–292. 72 indexed citations

12.

Abraham, Michal, Katia Beider, Hanna Wald, et al.. (2009). The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation. Leukemia. 23(8). 1378–1388. 33 indexed citations

13.

Beni‐Adani, Liana, Illana Gozes, Yoram Cohen, et al.. (2001). A Peptide Derived from Activity-Dependent Neuroprotective Protein (ADNP) Ameliorates Injury Response in Closed Head Injury in Mice. Journal of Pharmacology and Experimental Therapeutics. 296(1). 57–63. 204 indexed citations

14.

Monsonego, Alon, et al.. (1997). Expression of GTP-dependent and GTP-independent Tissue-type Transglutaminase in Cytokine-treated Rat Brain Astrocytes. Journal of Biological Chemistry. 272(6). 3724–3732. 92 indexed citations

15.

Monsonego, Alon, et al.. (1997). Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes.. Journal of Biological Chemistry. 272(11). 7565–7565. 6 indexed citations

16.

Eizenberg, Orly, Anat Faber‐Elman, Eyal Gottlieb, et al.. (1996). p53 Plays a Regulatory Role in Differentiation and Apoptosis of Central Nervous System-Associated Cells. Molecular and Cellular Biology. 16(9). 5178–5185. 177 indexed citations

17.

Eizenberg, Orly, et al.. (1995). Interleukin‐2 Transcripts in Human and Rodent Brains: Possible Expression by Astrocytes. Journal of Neurochemistry. 64(5). 1928–1936. 45 indexed citations

18.

Eizenberg, Orly, Michael G. Kaplitt, Shoshana Eitan, et al.. (1994). Linear dimeric interleukin-2 obtained by the use of a defective herpes simplex viral vector: conformation-activity relationship. Molecular Brain Research. 26(1-2). 156–162. 2 indexed citations

19.

Eizenberg, Orly & Moshe Oren. (1991). Reduced levels of α1 (I) collagen mRNA in cells immortalized by mutant p53 or transformed by ras. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1129(1). 34–42. 6 indexed citations

20.

Rozenblatt, Shmuel, Orly Eizenberg, R Ben-Levy, Vered Lavie, & William J. Bellini. (1985). Sequence homology within the morbilliviruses. Journal of Virology. 53(2). 684–690. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact